Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever

Lassa fever (LF), caused by Lassa virus (LASV), is a viral hemorrhagic fever for which no approved vaccine or potent antiviral treatment is available. LF is a WHO priority disease and, together with rabies, a major health burden in West Africa. Here we present the development and characterization of...

Descripción completa

Detalles Bibliográficos
Autores principales: Abreu-Mota, Tiago, Hagen, Katie R., Cooper, Kurt, Jahrling, Peter B., Tan, Gene, Wirblich, Christoph, Johnson, Reed F., Schnell, Matthias J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181965/
https://www.ncbi.nlm.nih.gov/pubmed/30310067
http://dx.doi.org/10.1038/s41467-018-06741-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181965/
https://www.ncbi.nlm.nih.gov/pubmed/30310067
http://dx.doi.org/10.1038/s41467-018-06741-w

Ejemplares similares